Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Emil Christensen(Aarhus University Hospital), Lars Dyrskjøt(Aarhus University Hospital), Philippe Lamy(Aarhus University Hospital), Sara K. Elbæk(Aarhus University), Iver Nordentoft(Aarhus University Hospital), Trine Strandgaard(Aarhus University), Tine G. Andreasen(Aarhus University), Sia V. Lindskrog(Aarhus University), Mads Agerbæk(Aarhus University Hospital), Michael Knudsen(Aarhus University Hospital), Ann Taber(Aarhus University Hospital), Jørgen Bjerggaard Jensen(University Psychiatric Hospital), Karin Birkenkamp‐Demtröder(Aarhus University Hospital)
Cited by 73
Related Papers
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
|Journal of Clinical Oncology|2019|540